In vivo carotid plaque MRI using quantitative T2 measurements with ultrasmall superparamagnetic iron oxide particles: A dose-response study to statin therapy

NMR in Biomedicine

Volumn 24, Issue 1, 2011, Pages 89-95

  Patterson, Andrew J ^a   Tang, Tjun Y ^a   Graves, Martin J ^a   Müller, Karin H ^b   Gillard, Jonathan H ^a  

^a CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Atherosclerosis; Contrast agent; Quantitative MRI

Indexed keywords

ALTERNATIVE METHODS; ATHEROSCLEROSIS; ATORVASTATIN; BEFORE AND AFTER; CAROTID PLAQUES; CAROTID STENOSIS; CONTRAST AGENT; DOSE RESPONSE; DOSE-RESPONSE STUDY; GRADIENT ECHO; HIGH DOSE; IN-VIVO; INVERSION RECOVERY; LINEAR MIXED-EFFECTS MODEL; LOW DOSE; PHANTOM STUDIES; QUANTITATIVE MRI; SIGNAL INTENSITIES; SIGNAL INTENSITY MEASUREMENTS; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;

CONCENTRATION (PROCESS); DISEASES; MEASUREMENTS; METAL RECOVERY; PATIENT REHABILITATION; SUPERPARAMAGNETISM; TISSUE;

IRON OXIDES;

ATORVASTATIN; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;

AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; CARDIAC IMAGING; CAROTID ARTERY OBSTRUCTION; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MEGADOSE; FEMALE; HUMAN; LOW DRUG DOSE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

AGED; CAROTID ARTERIES; DEXTRANS; DOSE-RESPONSE RELATIONSHIP, DRUG; ECHO-PLANAR IMAGING; FEMALE; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MAGNETIC RESONANCE ANGIOGRAPHY; MAGNETITE NANOPARTICLES; MALE; PHANTOMS, IMAGING; PYRROLES;

EID: 78851469099     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.1560     Document Type: Article

References (23)

1. Spagnoli LG, Mauriello A, Sangiorgi G, Fratoni S, Bonanno E, Schwartz RS, Piepgras DG, Pistolese R, Ippoliti A, Holmes DR Jr. Extracranial thrombotically active carotid plaque as a risk factor for ischemic stroke. J. Am. Med. Assoc. 2004; 292: 1845-1852.
2. Redgrave JN, Lovett JK, Gallagher PJ, Rothwell PM. Histological assessment of 526 symptomatic carotid plaques in relation to the nature and timing of ischemic symptoms: the Oxford plaque study. Circulation 2006; 113: 2320-2328.
3. U-King-Im JM, Tang TY, Patterson A, Graves MJ, Howarth S, Li ZY, Trivedi R, Bowden D, Kirkpatrick PJ, Gaunt ME, Warburton EA, Antoun NM, Gillard JH. Characterisation of carotid atheroma in symptomatic and asymptomatic patients using high resolution MRI. J. Neurol. Neurosurg. Psychiatry 2008; 79: 905-912.
4. Kooi ME, Cappendijk VC, Cleutjens KB, Kessels AG, Kitslaar PJ, Borgers M, Frederik PM, Daemen MJ, van Engelshoven JM. Accumulation of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaques can be detected by in vivo magnetic resonance imaging. Circulation 2003; 107: 2453-2458.
5. Trivedi RA, Mallawarachi C, U-King-Im JM, Graves MJ, Horsley J, Goddard MJ, Brown A, Wang L, Kirkpatrick PJ, Brown J, Gillard JH. Identifying inflamed carotid plaques using in vivo USPIO-enhanced MR imaging to label plaque macrophages. Arterioscler. Thromb. Vasc. Biol. 2006; 26: 1601-1606.
6. Tang TY, Howarth SP, Miller SR, Graves MJ, U-King-Im JM, Trivedi RA, Li ZY, Walsh SR, Brown AP, Kirkpatrick PJ, Gaunt ME, Gillard JH. Comparison of the inflammatory burden of truly asymptomatic carotid atheroma with atherosclerotic plaques contralateral to symptomatic carotid stenosis: an ultra small superparamagnetic iron oxide enhanced magnetic resonance study. J. Neurol. Neurosurg. Psychiatry 2007; 78: 1337-1343.
7. Howarth SP, Tang TY, Trivedi R, Weerakkody R, U-King-Im JM, Gaunt ME, Boyle JR, Li ZY, Miller SR, Graves MJ, Gillard JH. Utility of USPIO-enhanced MR imaging to identify inflammation and the fibrous cap: a comparison of symptomatic and asymptomatic individuals. Eur. J. Radiol. 2009; 70: 555-560.
8. Trivedi RA, U-King-Im JM, Graves MJ, Kirkpatrick PJ, Gillard JH. Noninvasive imaging of carotid plaque inflammation. Neurology 2004; 63: 187-188.
9. Tang TY, Howarth SP, Miller SR, Graves MJ, Patterson AJ, U-King-Im JM, Li ZY, Walsh SR, Brown AP, Kirkpatrick PJ, Warburton EA, Hayes PD, Varty K, Boyle JR, Gaunt ME, Zalewski A, Gillard JH. The ATHEROMA (Atorvastatin Therapy: Effects on Reduction of Macrophage Activity) Study. Evaluation using ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging in carotid disease. J. Am. Coll. Cardiol. 2009; 53: 2039-2050.
10. Fayad ZA, Razzouk L, Briley-Saebo KC, Mani V. Iron oxide magnetic resonance imaging for atherosclerosis therapeutic evaluation: still 'rusty'? J. Am. Coll. Cardiol. 2009; 53: 2051-2052.
11. Yarnykh VL, Yuan C. T1-insensitive flow suppression using quadruple inversion-recovery. Magn. Reson. Med. 2002; 48: 899-905.
12. Tang TY, Howarth SP, Miller SR, Graves MJ, U-King-Im JM, Li ZY, Walsh SR, Patterson AJ, Kirkpatrick PJ, Warburton EA, Varty K, Gaunt ME, Gillard JH. Correlation of carotid atheromatous plaque inflammation using USPIO-enhanced MR imaging with degree of luminal stenosis. Stroke 2008; 39: 2144-2147.
13. Trivedi RA, U-King-Im JM, Graves MJ, Cross JJ, Horsley J, Goddard MJ, Skepper JN, Quartey G, Warburton E, Joubert I, Wang L, Kirkpatrick PJ, Brown J, Gillard JH. In vivo detection of macrophages in human carotid atheroma: temporal dependence of ultrasmall superparamagnetic particles of iron oxide-enhanced MRI. Stroke 2004; 35: 1631-1635.
14. Miller AJ, Joseph PM. The use of power images to perform quantitative analysis on low SNR MR images. Magn. Reson. Imaging 1993; 11: 1051-1056.
15. Carneiro AAO, Vilela GR, Araujo DBd, Baffa O. MRI relaxometry: methods and applications. Braz. J. Phys. 2006; 36: 9-15.
16. Press WH. Numerical Recipes in C++: the Art of Scientific Computing. Cambridge: Cambridge University Press, 2002.
17. Patterson AJ, Graves MJ, Tang TY, Gillard JH. Comparison of ASSETx1 and corrected power images for T2 quantification. Proc. Int. Soc. Mag. Med. 2008; 16: 1523.
18. Faraway JJ. Extending the Linear Model with R: Generalized Linear, Mixed Effects and Nonparametric Regression Models. Chapman & Hall/CRC: Boca Raton, FL/London; 2006.
19. Fayad ZA, Fuster V. Characterization of atherosclerotic plaques by magnetic resonance imaging. Ann. NY Acad. Sci. 2000; 902: 173-186.
20. Saam T, Hatsukami TS, Takaya N, Chu B, Underhill H, Kerwin WS, Cai J, Ferguson MS, Yuan C. The vulnerable, or high-risk, atherosclerotic plaque: noninvasive MR imaging for characterization and assessment. Radiology 2007; 244: 64-77.
21. Yuan C, Mitsumori LM, Beach KW, Maravilla KR. Carotid atherosclerotic plaque: noninvasive MR characterization and identification of vulnerable lesions. Radiology 2001; 221: 285-299.
22. McLachlan SJ, Morris MR, Lucas MA, Fisco RA, Eakins MN, Fowler DR, Scheetz RB, Olukotun AY. Phase I clinical evaluation of a new iron oxide MR contrast agent. J. Magn. Reson. Imaging 1994; 4: 301-307.
23. Simon GH, Bauer J, Saborovski O, Fu Y, Corot C, Wendland MF, Daldrup-Link HE. T1 and T2 relaxivity of intracellular and extracellular USPIO at 1.5T and 3T clinical MR scanning. Eur. Radiol. 2006; 16: 738-745.